Dyadic International Inc DYAI:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/08/21 EST
5.13quote price arrow up+0.18 (+3.64%)
Volume
158,898
52 week range
2.51 - 10.98

...

Loading . . .

KEY STATS

  • Open4.98
  • Day High5.16
  • Day Low4.92
  • Prev Close5.13
  • 52 Week High10.98
  • 52 Week High Date06/26/20
  • 52 Week Low2.51
  • 52 Week Low Date03/18/20
  • Market Cap140.97M
  • Shares Out27.48M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.07
  • 1 Year % Change-3.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.33
  • P/E (TTM)-15.46
  • Fwd P/E (NTM)30.18
  • EBITDA (MRQ)-9.664M
  • ROE (MRQ)-27.08%
  • Revenue (MRQ)1.69M
  • Gross Margin (MRQ)5.63%
  • Net Margin (MRQ)-538.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Dyadic International Inc News

There is no recent news for this security.

Latest DYAI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Dyadic International, Inc. is a global biotechnology company. The Company is focused on developing and licensing the C1 platform for use in human and animal pharmaceutical applications across the world. The Company has developed a method for producing commercial quantities of enzymes and other proteins, which it uses to develop and produce some of its own industrial enzymes, as well as licensing this technology to third parties. This technology is based on the Myceliopthora...
Michael Tarnok
Chairman
Mark Emalfarb
President
Ping Rawson CPA
Chief Financial Officer
Address
140 Intracoastal Pointe Dr Ste 404
Jupiter, FL
33477-5094
United States